

[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire
[ Fri, Sep 11th 2009
] - Market Wire

[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - Market Wire
[ Thu, Sep 10th 2009
] - WOPRAI
[ Thu, Sep 10th 2009
] - WOPRAI
[ Thu, Sep 10th 2009
] - WOPRAI
Oncothyreon to present at BioCentury NewsMakers Conference
SEATTLE, Sept. 10 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the 16th Annual BioCentury NewsMakers in the Biotech Industry Conference on Sept. 16, 2009 in New York. Dr. Kirkman will present at 3 p.m. Eastern Time. A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website [ www.oncothyreon.com ] under the "News & Events" section. The NewsMakers Conference is designed to stimulate interest in a select group of public biotech companies and is recognized as a key venue for reaching financial professionals including financial institutions, pharmaceutical business development groups, and high net worth investors active in the sector. About Oncothyreon Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit [ www.oncothyreon.com ].
For further information: Investor and Media Relations Contact: Julie Rathbun, Rathbun Communications, (206) 769-9219, [ ir@oncothyreon.com ]
Similar Health and Fitness Articles
[ Wed, Sep 09th 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Tue, Aug 04th 2009
] - Market Wire
[ Mon, Aug 03rd 2009
] - Market Wire
[ Mon, Jun 15th 2009
] - Market Wire
[ Sat, May 30th 2009
] - Market Wire
[ Mon, May 18th 2009
] - Market Wire
[ Mon, May 18th 2009
] - Market Wire